Found: 9
Select item for more details and to access through your institution.
Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
- Published in:
- Oncogene, 2002, v. 21, n. 17, p. 2613, doi. 10.1038/sj.onc.1205353
- By:
- Publication type:
- Article
Characterization of a new human glioblastoma cell line that expresses mutant P53 and lacks activation of the PDGF pathway.
- Published in:
- In Vitro Cellular & Developmental Biology Animal, 1995, v. 31, n. 3, p. 207, doi. 10.1007/BF02639435
- By:
- Publication type:
- Article
Characterization of Hemodynamic Events Following Intravascular Infusion of Recombinant Adenovirus Reveals Possible Solutions for Mitigating Cardiovascular Responses
- Published in:
- Molecular Therapy, 2005, v. 12, n. 2, p. 254, doi. 10.1016/j.ymthe.2005.03.007
- By:
- Publication type:
- Article
749. Characterization of Adenovirus-Mediated Gene Expression in Normal, Wounded and Wound Impaired Skin
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Development of a formulation that enhances gene expression and efficacy following intraperitoneal administration in rabbits and mice
- Published in:
- Molecular Therapy, 2003, v. 7, n. 4, p. 558, doi. 10.1016/S1525-0016(03)00057-1
- By:
- Publication type:
- Article
Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 3, p. 224, doi. 10.1038/sj.cgt.7700562
- By:
- Publication type:
- Article
Ex vivo purging by adenoviral p53 gene therapy does not affect NOD-SCID repopulating activity of human CD34<sup>+</sup> cells.
- Published in:
- Cancer Gene Therapy, 2001, v. 8, n. 12, p. 936, doi. 10.1038/sj.cgt.7700390
- By:
- Publication type:
- Article
Interferon α2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers.
- Published in:
- Cancer Gene Therapy, 2001, v. 8, n. 10, p. 788, doi. 10.1038/sj.cgt.7700364
- By:
- Publication type:
- Article
Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 11, p. 1469, doi. 10.1038/sj.cgt.7700257
- By:
- Publication type:
- Article